col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Wiley: British Journal of Dermatology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―26 Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1,326,312 patients in France L. Penso, R. Dray-Spira, A. Weill, M. Zureik, E. Sbidian
2 [GO] 2021―Jul―14 Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic C. Cassius, M. Merandet, L. Frumholtz, D. Bergerat, A. Samri, C. Grolleau, et al. (+10)
3 [GO] 2021―Jul―13 Cutaneous reactions after SARS-COV-2 vaccination: A cross-sectional Spanish nationwide study of 405 cases A. Català, C. Muñoz-Santos, C. Galván-Casas, M. Roncero Riesco, D. Revilla Nebreda, A. Solá-Truyols, et al. (+34)
4 [GO] 2021―Jul―06 GIRFT06: Dermatology high-cost drug management: pharmacists getting it right first time in COVID-19
5 [GO] 2021―Jul―06 DS26: COVID-19 and reduced detection of malignant melanoma in secondary dermatology services
6 [GO] 2021―Jul―06 DT04: Pandemic placement: delivering the dermatology undergraduate curriculum at a UK medical school during the COVID-19 crisis
7 [GO] 2021―Jul―06 BT10: Medical education in the COVID-19 era: a remote dermatology attachment
8 [GO] 2021―Jul―06 DS06: Contending with COVID-19 in a Mohs micrographic surgery service
9 [GO] 2021―Jul―06 P19: Cutaneous manifestations of COVID-19 in the UK: a registry of digital submissions from interdisciplinary healthcare professionals
10 [GO] 2021―Jul―06 DP16: Severe, ulcerative cold panniculitis following COVID-19 infection
11 [GO] 2021―Jul―06 DP08: Leprosy unmasked by COVID-19 infection: a new diagnosis of leprosy with development of type 1 reversal reaction
12 [GO] 2021―Jul―06 DS25: Pandemic pressures: the impact of COVID-19 on the 2-week-wait service at a regional skin oncology centre
13 [GO] 2021―Jul―06 P28: The effects of COVID-19 on undergraduate dermatology training: a qualitative study
14 [GO] 2021―Jul―06 BT19: The use of a novel teledermatology/teledermoscopy service to maintain a dermatology cancer service in the midst of the COVID-19 pandemic
15 [GO] 2021―Jul―06 BT18: A new era for teledermatology in the COVID-19 pandemic
16 [GO] 2021―Jul―06 BT16: Disaster-recovery modelling to shape services: a dermatology helpline as a telemedicine intervention during the initial surge of the COVID-19 pandemic
17 [GO] 2021―Jul―06 PD11: Access to phototherapy during the COVID-19 pandemic
18 [GO] 2021―Jul―06 BT14: Exploring the feasibility of a remote acne service: a report of a pilot study using the MySkinSelfie platform during the COVID-19 pandemic
19 [GO] 2021―Jul―06 BT09: Standard of patient-sent images in teledermatology 2-week-wait skin cancer clinics during the COVID-19 pandemic
20 [GO] 2021―Jul―06 BI08: Remote management of immunotherapy-induced bullous pemphigoid during the COVID-19 pandemic
21 [GO] 2021―Jul―06 DS14: Experience of using a scar-assessment tool to evaluate scars after Mohs surgery via virtual consultation during the COVID-19 pandemic
22 [GO] 2021―Jul―06 P57: Surprising trends in the detection of cutaneous malignancy during the COVID-19 pandemic
23 [GO] 2021―Jul―06 BT15: Evaluating paediatric dermatology telephone clinics during the COVID-19 pandemic in a UK cohort: a prospective study
24 [GO] 2021―Jul―06 DS23: A multicentre qualitative study of patients’ experience of skin surgery during the COVID-19 pandemic in the UK
25 [GO] 2021―Jul―06 DT07: The impact of the COVID-19 pandemic on dermatology ST3 application preparation: a national survey of junior doctors in the UK
26 [GO] 2021―Jul―06 BI07: The effect of the COVID-19 pandemic on immunosuppressed patients undergoing skin surveillance
27 [GO] 2021―Jul―06 O01: The impact of the COVID-19 pandemic on people with psoriasis: findings from a global patient-reported registry
28 [GO] 2021―Jul―06 P25: The impact of the second wave of the COVID-19 pandemic on the quality of life of patients with skin cancer
29 [GO] 2021―Jul―06 CD08: Occupational dermatoses during the second COVID-19 pandemic wave: an audit of 401 healthcare workers
30 [GO] 2021―Jul―06 P38: Mental health of patients with psoriasis during the COVID-19 pandemic: a cross-sectional study in a tertiary setting
31 [GO] 2021―Jul―06 PS06 (P38): Mental health of patients with psoriasis during the COVID-19 pandemic: a cross-sectional study in a tertiary setting
32 [GO] 2021―Jul―06 BT12: The environmental impact of teledermatology in the COVID-19 pandemic: a silver lining
33 [GO] 2021―Jul―06 CD07: A survey of the incidence of skin problems in a cohort of hospital staff during the COVID-19 pandemic: can this help plan future services?
34 [GO] 2021―Jul―06 DT03: Diversifying educational resources during the COVID-19 pandemic: delivering educational dermatology podcasts and webinars for healthcare professionals
35 [GO] 2021―Jul―06 BT04: A new virtual inpatient dermatology electronic referral service: a timely answer to reducing cross-contamination during the COVID-19 pandemic?
36 [GO] 2021―Jul―06 DT02: What has been the impact of COVID-19 redeployment on dermatology trainees’ professional identity? An interpretative phenomenological study
37 [GO] 2021―Jul―06 P21: Practising dermatology in the era of COVID-19: a tertiary centre’s experience of adapting to change
38 [GO] 2021―Jul―06 PD14: Treating field cancerization in a time of COVID-19: daylight photodynamic therapy is effective, socially distant and satisfactory to our most vulnerable patients
39 [GO] 2021―Jul―06 P46: Occupational dermatoses during COVID-19: effect on work and wellbeing
40 [GO] 2021―Jul―06 P62: An increase in Breslow thickness: coronavirus or coincidence?
41 [GO] 2021―Jul―06 PD05: Skin safety and efficacy of filtered far ultraviolet C for SARS-CoV-2 inactivation
42 [GO] 2021―Jul―06 CD09: A review of semi-virtual patch testing during the SARS-CoV-2 pandemic: practicalities and patient experience
43 [GO] 2021―Jul―06 Primary cutaneous anaplastic large cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination T. Gambichler, S. Boms, S. Hessam, I. Tischoff, A. Tannapfel, T. Lüttringhaus, et al. (+2)
44 [GO] 2021―Jul―06 P24: Dermatology medical student history taking via the telephone: a way to minimize disruption to medical education, particularly during a pandemic
45 [GO] 2021―Jul―06 P73: A novel approach to systemic monitoring in a pandemic
46 [GO] 2021―Jul―05 Yet another benefit from sunlight in the fight against COVID-19? R.L. McKenzie, J.B. Liley
47 [GO] 2021―Jul―03 在 2019 年新型冠状病毒疾病 (COVID-19) 疫情期间, 银屑病或关节病患者的隔离因治疗类型而异
48 [GO] 2021―Jul―03 Shielding behaviour in people with psoriasis or a joint condition during the COVID-19 pandemic differs by treatment type
49 [GO] 2021―Jun―15 Relapse of chilblain-like lesions during the second COVID-19 pandemic wave: a cohort follow-up T. Hubiche, F. Le Duff, E. Fontas, J. Rapp, C. Chiaverini, T. Passeron
50 [GO] 2021―Jun―11 Kawasaki-like Multisystem Inflammatory Syndrome Associated with Coronavirus disease 2019 in an Adult: A case report R. Dabas, G. Varadaraj, S. Sandhu, A. Bhatnagar, R. Pal
51 [GO] 2021―Jun―09 COVID-19 outcomes in patients with autoimmune blistering disease E. Hwang, M.M. Tomayko
52 [GO] 2021―May―25 COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations M. Razmi T, T.P. Afra, T.P. Mohammed, P.T.M. Ashik, E. Sukesh
53 [GO] 2021―May―20 Forewarned is Forearmed: chronic spontaneous urticaria as a potential risk to effective SARS-COV-2 vaccine uptake and global public health W.H. Bermingham, M.R. Ardern-Jones, A.P. Huissoon, M.T. Krishna
54 [GO] 2021―May―19 Skin checks and skin cancer diagnosis in Australian general practice before and during the COVID pandemic, 2011-2020 J. Roseleur, D.A. Gonzalez-Chica, J. Emery, N.P. Stocks
55 [GO] 2021―May―17 Rarity of cutaneous findings among asymptomatic to mildly symptomatic COVID-19 patients admitted to a COVID Care facility in Delhi, India: An observational study A. Khurana, A. Mittal, R. Jain, A. Mishra, S.R. Mathachan
56 [GO] 2021―May―13 Antibody responses to single-dose SARS-CoV-2 vaccination in patients receiving immunomodulators for immune-mediated inflammatory disease A. Al-Janabi, Z. Littlewood, C.E.M. Griffiths, H.J.A. Hunter, H. Chinoy, C. Moriarty, et al. (+2)
57 [GO] 2021―May―07 SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study C. Nguyen, K. Yale, F. Casale, A. Ghigi, K. Zheng, J.I. Silverberg, N.A. Mesinkovska
58 [GO] 2021―May―06 Psoriasis, COVID-19 and shielding G. Becher, A.D. Burden
59 [GO] 2021―May―05 Diagnosis of COVID-19 using skin rashes
60 [GO] 2021―May―03 The impact of the COVID-19 pandemic on skin cancer incidence and treatment in England, 2020 Z.C. Venables, S. Ahmed, T. Bleiker, J. Broggio, M. Kwiatkowska, N.J. Levell, et al. (+6)
61 [GO] 2021―Apr―27 Chilblain lesions after COVID-19 mRNA vaccine A. Pileri, A. Guglielmo, B. Raone, A. Patrizi
62 [GO] 2021―Apr―27 Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination A.M. Carballido Vázquez, B. Morgado
63 [GO] 2021―Apr―24 Pernio after COVID-19 Vaccination S. Lopez, P. Vakharia, T. Vandergriff, E.E. Freeman, R. Vasquez
64 [GO] 2021―Apr―10 Outcomes of COVID-19 in Patients with Skin Cancer R. Raiker, H. Pakhchanian, A. Hussain, M. Deng
65 [GO] 2021―Apr―09 Ultraviolet A Radiation and COVID-19 Deaths in the USA with replication studies in England and Italy M. Cherrie, T. Clemens, C. Colandrea, Z. Feng, D.J. Webb, R.B. Weller, C. Dibben
66 [GO] 2021―Mar―18 Recurrence of chilblains during a second contact with SARS-CoV-2: a case report S. Maanaoui, F. Salez, O. Carpentier
67 [GO] 2021―Mar―17 Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single centre, cross-sectional study Z.Z.N. Yiu, G. Harding, C.E.M. Griffiths, R.B. Warren, E. McMullen, H.J.A. Hunter
68 [GO] 2021―Mar―04 The skin as a target for SARS-CoV-2 infection: exploiting the web for suitable data L. Naldi
69 [GO] 2021―Mar―03 Cold and COVID: Recurrent Pernio during the COVID-19 Pandemic E.E. Freeman, D.E. McMahon, J.B. Lipoff, M. Rosenbach, S.R. Desai, M. Fassett, et al. (+4)
70 [GO] 2021―Feb―20 Intention of COVID-19 vaccination among psoriatic patients compared to immunosuppressed patients with other skin diseases and factors influencing their decision E. Sotiriou, K. Bakirtzi, I. Papadimitriou, E. Paschou, E. Vakirlis, A. Lallas, D. Ioannides
71 [GO] 2021―Feb―08 COVID-19 相关的皮肤疾病以及相关生物制剂
72 [GO] 2021―Feb―08 Association of COVID-19 with skin diseases and relevant biologics
73 [GO] 2021―Jan―29 SARS-CoV-2 Spike Protein Positivity in Pityriasis Rosea-like and Urticaria-like Rashes of COVID-19 E. Welsh, J.A. Cardenas-de la Garza, A. Cuellar-Barboza, R. Franco-Marquez, R.I. Arvizu-Rivera
74 [GO] 2021―Jan―17 Oral ivermectin for a scabies outbreak in a long-term-care facility: Potential value in preventing COVID-19 and associated mortality? C. Bernigaud, D. Guillemot, A. Ahmed-Belkacem, L. Grimaldi-Bensouda, A. Lespine, F. Berry, et al. (+6)
75 [GO] 2021―Jan―15 Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection A. Visconti, V. Bataille, N. Rossi, J. Kluk, R. Murphy, S. Puig, et al. (+9)
76 [GO] 2021―Jan―14 COVID-19-associated cutaneous manifestations: does HHV-6 play an etiological role? I. Abadías-Granado, A. Navarro-Bielsa, A.M. Morales-Callaghan, L. Roc, C.C. Suso-Estívalez, M. Povar-Echeverría, Y. Gilaberte
77 [GO] 2021―Jan―10 COVID-19 related dermatosis in November 2019. Could this case be Italy’s patient zero? R. Gianotti, M. Barberis, G. Fellegara, C. Galván-Casas, E. Gianotti
78 [GO] 2020―Dec―24 Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey S.K. Mahil, M. Yates, S.M. Langan, Z.Z.N. Yiu, T. Tsakok, N. Dand, et al. (+37)
79 [GO] 2020―Dec―16 SARS-CoV-2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions: reply from the authors I. Colmenero, C. Santonja, M. Alonso-Riaño, D. Andina, J.L. Rodríguez Peralto, L. Requena, A. Torrelo
80 [GO] 2020―Dec―10 Response to Tembhre et al.: ‘Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2’ J.R. Gehlhausen, C.J. Ko, W. Damsky
81 [GO] 2020―Dec―04 Association of skin diseases, biological treatment and COVID-19 during the first wave of the pandemic M.A. Descalzo, I. Garcia-Doval
82 [GO] 2020―Nov―29 Impaired type I interferon response in SARS-CoV-2 infection: looking through the cutaneous window D. Bessis
83 [GO] 2020―Nov―06 Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2 M.K. Tembhre, A.S. Parihar, V.K. Sharma, S. Imran, N. Bhari, R. Lakshmy, A. Bhalla
84 [GO] 2020―Nov―05 Response to “Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic G. Murray, D. Roche, A. Ridge, C. Hackett, A.M. Tobin
85 [GO] 2020―Nov―03 Oral vesiculobullous lesions as an early sign of COVID-19: immunohistochemical detection of SARS-CoV-2 spike protein C.D. Soares, A. Mosqueda-Taylor, M.G.F. Carvalho, O.P. Almeida
86 [GO] 2020―Nov―02 COVID-19 疫情期间观察到的大多数冻疮与 COVID-19 感染无关
87 [GO] 2020―Nov―02 Most chilblains observed during the COVID-19 outbreak are not linked to COVID-19 infection
88 [GO] 2020―Oct―28 Occupational dermatoses during the Covid-19 pandemic: a multicentre audit in the UK and Ireland H. O’Neill, I. Narang, D.A. Buckley, T.A. Phillips, C.G. Bertram, T.O. Bleiker, et al. (+9)
89 [GO] 2020―Oct―26 Prurigo pigmentosa and new-onset type 1 diabetes in a black female patient testing positive for SARS-CoV-2 IgG K.M. Derrick, D.R. Mazori, E.R. Heilman, S.A. Glick
90 [GO] 2020―Oct―05 SARS-CoV-2 导致冠状病毒脚趾
91 [GO] 2020―Oct―05 SARS-CoV-2 causes Covid Toes
92 [GO] 2020―Oct―01 SARS-CoV-2 Has Not Been Detected Directly by Electron Microscopy in the Endothelium of Chilblain Lesions: reply from authors I. Colmenero, C. Santonja, M. Alonso-Riaño, D. Andina, J.L. Rodríguez Peralto, L. Requena, A. Torrelo
93 [GO] 2020―Oct―01 SARS-CoV-2 Has Not Been Detected Directly by Electron Microscopy in the Endothelium of Chilblain Lesions J.K. Brealey, S.E. Miller
94 [GO] 2020―Sep―25 Response to ‘No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain’. Reply from the authors D. Caselli, M. Chironna, D. Loconsole, M. Aricò
95 [GO] 2020―Sep―24 Prevalence of mucocutaneous manifestations, oral and palmoplantar findings in 666 patients with COVID-19 in a field hospital in Spain A. Nuno-Gonzalez, P. Martin-Carrillo, K. Magaletsky, M.D. Martin Rios, C. Herranz Mañas, J. Artigas Almazan, et al. (+11)
96 [GO] 2020―Sep―03 A review of studies into skin symptoms of COVID-19
97 [GO] 2020―Sep―03 COVID-19 皮肤症状研究综述
98 [GO] 2020―Sep―02 Association of COVID-19 with skin diseases and relevant biologics: a cross-sectional study using nationwide claim data in South Korea S.I. Cho, Y.E. Kim, S.J. Jo
99 [GO] 2020―Sep―01 COVID-19 Session
100 [GO] 2020―Sep―01 Illuminating, through immunohistochemistry, the link between SARS-CoV-2 and pernio (chilblains) D.A. Wetter
101 [GO] 2020―Aug―31 Paucity of COVID-19 Dermatology Literature from Low- and Middle-Income Countries R.S. Pendse, B.L. Schwartz, J.L. Jia, E.E. Bailey
102 [GO] 2020―Aug―28 COVID-19 in hidradenitis suppurativa patients X.T. Lima, M.A. Cueva, M.B. Alora
103 [GO] 2020―Aug―28 Response to “No evidence of SARS-CoV-2 infection by PCR or serology in children with pseudochilblain” S. Recalcati, S. Tonolo, F. Luzzaro, F. Fantini
104 [GO] 2020―Aug―15 Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned M. Baeck, D. Hoton, L. Marot, A. Herman
105 [GO] 2020―Aug―15 Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned: reply from authors I. Colmenero, C. Santonja, M. Alonso-Riaño, D. Andina, J.L. Rodríguez-Peralto, L. Requena, A. Torrelo
106 [GO] 2020―Aug―13 Co-Reactivation of Human Herpesvirus alpha Subfamily (HSV Ⅰ and VZV) in Critically Ill Patient with COVID-19 R. Xu, Y. Zhou, L. Cai, L. Wang, J. Han, X. Yang, et al. (+4)
107 [GO] 2020―Aug―13 Occupational Dermatology in the time of the Covid-19 pandemic: A report of experience from London and Manchester, United Kingdom F.J. Ferguson, G. Street, L. Cunningham, I.R. White, J.P. McFadden, J. Williams
108 [GO] 2020―Aug―13 Negative tests for SARS-CoV-2 infection do not rule out its responsibility for chilblains G. Battesti, V. Descamps Vincent
109 [GO] 2020―Aug―13 Negative tests for SARS-CoV-2 infection do not rule out its responsibility for chilblains: reply from authors L. Le Cleach, S. Fourati, E. Sbidian, M. Beylot-Barry
110 [GO] 2020―Jul―31 Cutaneous signs in SARS CoV-2 infection: A plea for more rigorous peer-review in the time of COVID-19 H. Kittler, P. Tschandl, W. Weninger
111 [GO] 2020―Jul―23 A Very Peculiar Practice: Dermatology in the era of Covid-19 S. Walsh, D. Creamer
112 [GO] 2020―Jul―22 The differing pathophysiologies that underlie COVID-19 associated perniosis and thrombotic retiform purpura: a case series C. Magro, J.J. Mulvey, J. Laurence, S. Sanders, N. Crowson, M. Grossman, et al. (+2)
113 [GO] 2020―Jul―22 High incidence of hand eczema in Danish school children following intensive hand hygiene during the COVID-19 pandemic - a nationwide questionnaire study A.B. Simonsen, I.F. Ruge, A.S. Q꫞, J.D. Johansen, J.P. Thyssen, C. Zachariae
114 [GO] 2020―Jul―06 Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on PCR and serology testing L. Le Cleach, L. Dousset, H. Assier, S. Fourati, S. Barbarot, C. Boulard, et al. (+15)
115 [GO] 2020―Jul―02 Identificadas las principales manifestaciones en la piel de la COVID-19
116 [GO] 2020―Jul―02 COVID-19 确诊患者的五种常见皮肤表现
117 [GO] 2020―Jul―02 Response to: “Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases”: Vesicular eruption in COVID-19 - to exclude varicella S.Y.D. Lim, H.L. Tey
118 [GO] 2020―Jul―02 “Vesicular eruption in COVID-19 - to exclude varicella”: reply from the authors A. Català, C. Galván Casas, G. Carretero Hernández, I. García-Doval
119 [GO] 2020―Jul―02 Five common skin manifestations of COVID-19 identified
120 [GO] 2020―Jul―02 Chilblain-like lesions during COVID-19 pandemic: a serological study on a case series L. Rizzoli, L. Collini, M. Magnano, S. Termine, R. Barcelli, S.D. Infusino, et al. (+4)
121 [GO] 2020―Jul―02 No evidence of SARS-Cov-2 infection by PCR or serology in children with pseudochilblain D. Caselli, M. Chironna, D. Loconsole, L. Nigri, F. Mazzotta, D. Bonamonte, M. Aricò
122 [GO] 2020―Jun―29 Global Hidradenitis Suppurativa COVID-19 Registry: A Registry to Inform Data-Driven Management Practices H.B. Naik, R. Alhusayen, J. Frew, S. Guilbault, J.R. Ingram, M.A. Lowes, et al. (+4)
123 [GO] 2020―Jun―25 COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a PCR-negative patient C. Santonja, F. Heras, L. Núñez, L. Requena
124 [GO] 2020―Jun―22 Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from authors C. Galván-Casas, A. Catalá, G. Carretero Hernández, I. Garcia-Doval
125 [GO] 2020―Jun―20 SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultraestructural study of 7 paediatric cases I. Colmenero, C. Santonja, M. Alonso-Riaño, L. Noguera-Morel, A. Hernández-Martín, D. Andina, et al. (+4)
126 [GO] 2020―Jun―17 SARS-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from the authors C. Galván Casas, A. Català, G. Carretero Hernández, I. García-Doval
127 [GO] 2020―Jun―15 Risk of infections in psoriasis. A lesson to learn during the SARS -CoV-2 pandemic L. Naldi
128 [GO] 2020―Jun―13 Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations F. Drago, G. Ciccarese, A. Rebora, S.I. Muzic, A. Parodi
129 [GO] 2020―Jun―05 Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic C.H. Earnshaw, H.J.A. Hunter, E. McMullen, C.E.M. Griffiths, R.B. Warren
130 [GO] 2020―Jun―01 Bullous skin disease patients in a high-epidemic COVID-19 area, Bergamo, Italy A. Carugno, P. Sena, F. Raponi, E. Robustelli Test, P. Vezzoli
131 [GO] 2020―Jun―01 Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue A.V. Marzano, N. Cassano, G. Genovese, C. Moltrasio, G.A. Vena
132 [GO] 2020―Jun―01 Emergency management of 2019 novel coronavirus: implications for the dermatology department J. Tao, Z. Song, L. Yang, C. Huang, A. Feng, X. Man
133 [GO] 2020―May―29 Absence of Skin of Colour Images in Publications of COVID-19 Skin Manifestations J.C. Lester, J.L. Jia, L. Zhang, G.A. Okoye, E. Linos
134 [GO] 2020―May―29 Virtual melanoma checks during a pandemic M. Janda, S.M. Swetter, C. Horsham, H.P. Soyer
135 [GO] 2020―May―27 Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection M. Hughes, S. Rogers, G. Lepri, C. Bruni, M. Matucci-Cerinic
136 [GO] 2020―May―14 Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient M. Llamas-Velasco, P. Muñoz-Hernández, J. Lázaro-González, A. Reolid-Pérez, B. Abad-Santamaría, J. Fraga, E. Daudén-Tello
137 [GO] 2020―Apr―30 Cutaneous lesions in a patient with COVID-19: are they related? B. Ahouach, S. Harant, A. Ullmer, P. Martres, E. Bégon, L. Blum, et al. (+2)
138 [GO] 2020―Apr―29 Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic S.K. Mahil, Z.Z.N. Yiu, K.J. Mason, N. Dand, B. Coker, D. Wall, et al. (+16)
139 [GO] 2020―Apr―29 Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases C. Galván Casas, A. Català, G. Carretero Hernández, P. Rodríguez-Jiménez, D. Fernández Nieto, A. Rodríguez-Villa Lario, et al. (+19)
140 [GO] 2020―Apr―28 The impact of COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biologic therapy: the Northern Italy experience P. Gisondi, P. Facheris, P. Dapavo, S. Piaserico, A. Conti, L. Naldi, et al. (+3)
141 [GO] 2020―Apr―17 Phototherapeutic approach to dermatological patients during the 2019 Coronavirus pandemic: Real-life Data from the Italian Red Zone A. Pacifico, M. Ardigò, P. Frascione, G. Damiani, A. Morrone
142 [GO] 2020―Apr―07 Adverse Skin Reactions Among Healthcare Workers During the Coronavirus Disease 2019 Outbreak: A Survey in Wuhan and Its Surrounding Regions P. Lin, S. Zhu, Y. Huang, L. Li, J. Tao, T. Lei, et al. (+17)
143 [GO] 2020―Mar―06 Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department J. Tao, Z. Song, L. Yang, C. Huang, A. Feng, X. Man


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.006 sec